Abstract
This initial discussion of dry eye in the patient with primary Sjögren’s syndrome (SS) is provided primarily for the non-ophthalmologist who will, hopefully, find useful the explanations of common diagnostic tests and therapeutic interventions employed in treating dry eye patients. A more detailed description of lacrimal gland and tear film physiology is presented in the chapter by Stern and Pflugfellder. In particular, the authors of this chapter have collaborated during the past 25 years on patients with dry eyes referred for evaluation and treatment of their SS. This chapter summarizes many of the common problems that the primary physician may refer to the rheumatologist and the “daily practical” questions from the SS patient that are not generally covered in academic reviews of dry eye care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lemp MA. Tear film: new concepts and implications for the management of the dry eye. Trans New Orleans Acad Ophthalmol. 1987;35:53–64.
Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea 2000;19(5):644–9.
Comment E. 2005 Gallup Study of dry eye sufferers: summary. Gallup Poll Summary. 2005. 2005:1–160.
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75–92.
Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006;25(8):900–7.
Lemp MA. Epidemiology and classification of dry eye. Adv Exp Med Biol. 1998;438:791–803.
Oden NL, Lilienfeld DE, Lemp MA, Nelson JD, Ederer F. Sensitivity and specificity of a screening questionnaire for dry eye. Adv Exp Med Biol. 1998;438:807–20.
Moss S, Klein R, Klein B. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264.
Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318–26.
Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–21.
Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology 2003;110(7):1412–9.
Thanou-Stavraki A, James JA. Primary Sjögren’s syndrome: current and prospective therapies. Semin Arthritis Rheum. 2008;37(5):273–92.
Jain AK, Sukhija J, Dwedi S, Sood A. Effect of topical cyclosporine on tear functions in tear-deficient dry eyes. Ann Ophthalmol (Skokie). 2007;39(1):19–25.
Strong B, Farley W, Stern ME, Pflugfelder SC. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea 2005;24(1):80–5.
O’Brien PD, Collum LM. Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep. 2004;4(4):314–19.
Tsubota K, Fujita H, Tadano K, et al. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren’s syndrome. Invest Ophthalmol Vis Sci. 2001;42(1):101–10.
Avunduk AM, Avunduk MC, Erdol H, Kapicioglu Z, Akyol N. Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis. Ophthalmologica 2001;215(4):290–3.
Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17(6):584–9.
Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984;27:459–61.
Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case–control study. Am J Ophthalmol. 2005;139(2):242–6.
Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res. 1998;17(4):565–96.
Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjögren’s syndrome [see comments]. Br J Ophthalmol. 1999;83(4):390–5.
Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. 2007;144(1):86–92.
Lockhart PB, Fox PC, Gentry AC, et al. Pilot study of controlled-release pilocarpine in normal subjects. Oral Surg, Oral Med, Oral Pathol, Oral Radiol and Endodontol. 1996;82(5):517–24.
Scholz OA, Wolff A, Schumacher A, et al. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. Drug Disc Today. 2008;13(5–6):247–53.
Frost-Larsen K, Isager H, Manthorpe, R. Sjogren syndrome treated with Bromhexine: a randomized clinical study. Br Med J. 1978(1):1579–84.
Manthorpe R, Frost-Larsen K, Hoj L, Isager H, Prause JU. Bromhexine treatment of Sjögren’s syndrome: effect on lacrimal and salivary secretion, and on proteins in tear fluid and saliva. Scand J Rheumatol. 1981;10:177–80.
Misawa M, Ohmori S, Yanaura S. Effects of bromhexine on the secretions of saliva and tears. J Pharmacol. 1985;39:241–50.
Azzarolo AM, Mircheff AK, Kaswan RL, et al. Androgen support of lacrimal gland function. Endocrine 1997;6(1):39–45.
Pillemer SR, Brennan MT, Sankar V, et al. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren’s syndrome. Arthritis Rheum. 2004;51(4):601–4.
Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol. 2003;136(4):593–602.
Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 1999;106(4):811–6.
Ponte F, Giuffre G, Giammanco R, Dardanoni G. Risk factors of ocular hypertension and glaucoma. The Casteldaccia Eye Study. Doc Ophthalmol. 1994;85(3):203–10.
Albietz JM, Lenton LM, McLennan SG. Dry eye after LASIK: comparison of outcomes for Asian and Caucasian eyes. Clin Exp Optom. 2005;88(2):89–96.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Michelson, P.E., Fox, R.I. (2011). Overview of Management of Dry Eye Associated with Sjögren’s Syndrome. In: Fox, R., Fox, C. (eds) Sjögren’s Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-60327-957-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-60327-957-4_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-60327-956-7
Online ISBN: 978-1-60327-957-4
eBook Packages: MedicineMedicine (R0)